These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22686252)

  • 21. Monofilament assessment of neuropathy in a community diabetes clinic.
    Rheeder P; van Wyk JT; Hokken JW; Hueting HM
    S Afr Med J; 2002 Sep; 92(9):715-9. PubMed ID: 12382357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study.
    Coppini DV; Young PJ; Weng C; Macleod AF; Sönksen PH
    Diabet Med; 1998 Sep; 15(9):765-71. PubMed ID: 9737806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuropad test for sudomotor function to predict the risk of diabetic foot ulceration].
    Qin Y; Cao Y; Gao F; Luo X; Li J; Fu X; Xue Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):560-2. PubMed ID: 24752109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic.
    Klenerman L; McCabe C; Cogley D; Crerand S; Laing P; White M
    Diabet Med; 1996 Jun; 13(6):561-3. PubMed ID: 8799661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
    Richard JL; Reilhes L; Buvry S; Goletto M; Faillie JL
    Int Wound J; 2014 Apr; 11(2):147-51. PubMed ID: 22892021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study.
    Panagoulias GS; Eleftheriadou I; Papanas N; Manes C; Kamenov Z; Tesic D; Bousboulas S; Tentolouris A; Jude EB; Tentolouris N
    Front Endocrinol (Lausanne); 2020; 11():625. PubMed ID: 33013702
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-invasive assessment of vibration perception and protective sensation in people with diabetes mellitus: inter- and intra-rater reliability.
    Lanting SM; Spink MJ; Tehan PE; Vickers S; Casey SL; Chuter VH
    J Foot Ankle Res; 2020; 13():3. PubMed ID: 31988664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuning fork (128 Hz) versus neurothesiometer: a comparison of methods of assessing vibration sensation in patients with diabetes mellitus.
    O'Neill J; McCann SM; Lagan KM
    Int J Clin Pract; 2006 Feb; 60(2):174-8. PubMed ID: 16451290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes.
    Olmos PR; Cataland S; O'Dorisio TM; Casey CA; Smead WL; Simon SR
    Am J Med Sci; 1995 Feb; 309(2):76-82. PubMed ID: 7847445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study on the significance of random intrasite placement of the Semmes-Weinstein monofilament.
    Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
    Diabetes Metab Res Rev; 2013 Mar; 29(3):235-8. PubMed ID: 23283830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical examination of the diabetic foot in daily practise.
    de Heus-van Putten MA; Schaper NC; Bakker K
    Diabet Med; 1996; 13 Suppl 1():S55-7. PubMed ID: 8741832
    [No Abstract]   [Full Text] [Related]  

  • 33. An assessment of vibration threshold using a biothesiometer compared to a C128-Hz tuning fork.
    Temlett JA
    J Clin Neurosci; 2009 Nov; 16(11):1435-8. PubMed ID: 19695882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The at-risk foot concerns not only patients with diabetes mellitus.
    Pataky Z; Herrmann FR; Regat D; Vuagnat H
    Gerontology; 2008; 54(6):349-53. PubMed ID: 18446046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.
    Gin H; Baudoin R; Raffaitin CH; Rigalleau V; Gonzalez C
    Diabetes Metab; 2011 Dec; 37(6):527-32. PubMed ID: 21715211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-invasive diagnosis of angiopathies and neuropathies in screening for the diabetic foot syndrome].
    Jirkovská A; Wosková V; Bartos V; Skibová J
    Vnitr Lek; 1998 May; 44(5):269-73. PubMed ID: 9820070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monofilament test in diabetic neuropathy].
    Valkonen O; Erkinjuntti M; Falck B; Rönnemaa T
    Duodecim; 2000; 116(19):2119-25. PubMed ID: 12017733
    [No Abstract]   [Full Text] [Related]  

  • 38. Reliability and responsiveness of an 18 site, 10-g monofilament examination for assessment of protective foot sensation.
    Young D; Schuerman S; Flynn K; Hartig K; Moss D; Altenburger B
    J Geriatr Phys Ther; 2011; 34(2):95-8. PubMed ID: 21937899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
    Oguejiofor OC; Odenigbo CU; Oguejiofor CB
    Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of different screening tests for detecting diabetic foot neuropathy.
    Forouzandeh F; Aziz Ahari A; Abolhasani F; Larijani B
    Acta Neurol Scand; 2005 Dec; 112(6):409-13. PubMed ID: 16281925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.